Glucose Health (GLUC) stock price, revenue, and financials

Glucose Health market cap is $643 k, and annual revenue was $313.23 k in FY 2016

$643 K

GLUC Mkt cap, 27-Nov-2020

$23.8 K

Glucose Health Revenue Q3, 2017
Glucose Health Gross profit (Q3, 2017)23 K
Glucose Health Gross profit margin (Q3, 2017), %96.7%
Glucose Health Net income (Q3, 2017)18.8 K
Glucose Health EBIT (Q3, 2017)4.6 K
Glucose Health Cash, 30-Sept-201716.6 K
Glucose Health EV646.4 K

Glucose Health Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

(224.0)2.7k4.3k313.2k

Cost of goods sold

2.3k23.5k3.9k294.1k

Gross profit

(2.5k)(20.7k)397.019.2k

Gross profit Margin, %

1133%(757%)9%6%

R&D expense

4.0k48.0

General and administrative expense

14.7k5.8k39.5k16.3k114.9k51.8k

Operating expense total

14.7k5.8k1.3m524.5k156.6k105.8k

EBIT

(888.8k)(361.4k)(1.3m)(545.2k)(156.2k)(86.6k)

EBIT margin, %

566645%(19906%)(3656%)(28%)

Interest expense

10.4k37.7k189.9k124.2k109.9k323.8k

Pre tax profit

(1.5m)(669.4k)(266.1k)(410.4k)

Net Income

(899.2k)(399.1k)(1.5m)(669.4k)(266.1k)(410.4k)

Glucose Health Balance Sheet

Quarterly

USDQ3, 2011Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

3.9k220.0277.02.8k16.5k269.0472.0879.03.0k4.2k8.8k1.9k27.8k23.6k9.0k18.3k16.6k

Accounts Receivable

2.0k3.2k168.3k11.7k9.6k8.8k9.1k

Prepaid Expenses

27.0k27.0k40.7k5.0k467.021.5k4.1k37.7k2.1k1.6k417.0

Inventories

83.3k43.9k27.9k23.7k15.1k12.9k12.5k11.7k9.7k8.3k8.3k6.4k

Current Assets

87.2k27.2k27.3k43.5k60.4k33.1k23.7k15.6k14.2k37.3k20.3k20.7k51.3k206.8k43.7k18.6k27.1k26.2k

Total Assets

287.2k233.8k233.9k250.1k492.0k464.7k23.7k15.6k14.2k37.6k20.6k21.0k51.6k207.1k44.0k18.9k27.3k26.4k

Accounts Payable

306.9k130.8k151.6k145.4k112.3k123.1k165.3k156.7k146.6k139.6k95.1k94.9k94.9k169.4k124.1k152.3k98.1k78.3k

Short-term debt

12.1k12.3k6.0k6.0k7.7k117.1k7.8k6.1k6.1k6.1k36.0k5.0k5.0k15.0k10.0k

Current Liabilities

565.8k179.5k457.9k358.4k234.7k242.4k220.5k238.1k263.6k369.8k350.9k382.8k454.8k423.8k417.6k542.4k476.6k452.6k

Long-term debt

Total Debt

12.1k12.3k6.0k6.0k7.7k117.1k7.8k12.2k12.2k12.2k72.0k40.0k10.0k30.0k20.0k

Total Liabilities

565.8k179.5k457.9k358.4k234.7k242.4k220.5k238.1k263.6k369.8k382.8k454.8k423.8k417.6k542.4k476.6k452.6k

Common Stock

41.2k67.2k74.3k116.6k156.9k174.8k21.4k24.1k29.9k1.8k2.1k2.2k2.5k2.8k3.0k3.4k4.0k4.5k

Preferred Stock

113.2k113.2k113.2k113.2k113.2k113.2k113.2k113.2k113.2k

Additional Paid-in Capital

2.6m3.3m3.5m3.8m4.4m4.4m4.8m4.9m5.0m5.3m5.3m5.4m5.4m5.7m5.7m5.7m5.7m5.7m

Retained Earnings

(2.9m)(2.9m)(2.9m)(2.9m)(2.9m)(2.9m)(2.9m)(5.1m)(5.2m)(5.7m)(5.7m)(5.8m)(5.9m)(6.0m)(6.1m)(6.3m)(6.2m)(6.2m)

Total Equity

(278.6k)54.3k(224.0k)(108.4k)257.3k222.3k(196.8k)(222.5k)(249.4k)(332.3k)(330.3k)(361.8k)(403.1k)(216.7k)(373.6k)(523.6k)(449.3k)(426.2k)

Debt to Equity Ratio

-0.1 x0 x0 x0 x0 x-0.5 x0 x0 x0 x0 x-0.3 x-0.1 x0 x-0.1 x0 x

Debt to Assets Ratio

0 x0 x0 x0.3 x0.5 x8.2 x0.2 x0.6 x0.6 x0.2 x0.3 x0.9 x0.5 x1.1 x0.8 x

Financial Leverage

-1 x4.3 x-1 x-2.3 x1.9 x2.1 x-0.1 x-0.1 x-0.1 x-0.1 x-0.1 x-0.1 x-0.1 x-1 x-0.1 x0 x-0.1 x-0.1 x

Glucose Health Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(899.2k)(399.1k)(1.5m)(669.4k)(266.1k)(410.4k)

Depreciation and Amortization

60.0

Accounts Receivable

(4.6k)(8.6k)

Inventories

(24.9k)10.5k(8.4k)(8.4k)

Accounts Payable

89.6k21.9k32.4k21.8k(59.7k)

Cash From Operating Activities

(23.3k)(83.7k)(132.0k)(135.4k)(115.8k)(39.3k)

Cash From Investing Activities

(250.0)250.0

Short-term Borrowings

1.4k(71.0k)

Cash From Financing Activities

20.8k78.6k131.6k139.5k113.2k57.5k

Net Change in Cash

49.0994.0(365.0)4.2k(2.8k)18.5k

Glucose Health Ratios

USDQ3, 2011

Financial Leverage

-1 x